Hemlibra

Active substance

Emicizumab

Holder

Roche

Status

Indication

Routine prophylaxis of bleeding episodes in patients with hemophilia A with factor VIII inhibitors. Hemlibra can be used in all age groups.

Public documents

Approbation

Information for the patient

Informed Consent

Last update